Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Keegan

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Archives of Neurology|September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patientsAnu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Biological Chemistry|July 17, 2008
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationIsobel A Scarisbrick, Rachel Linbo, Alexander G Vandell, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Multiple Sclerosis and Related Disorders|June 10, 2026
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndromeAlbert Aboseif, Nur Neyal, B Mark Keegan, et al.
Neurology|June 26, 2019
Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiologyElia Sechi, Eslam Shosha, Jonathan P Williams, et al.
Brain Communications|January 7, 2021
Reproductive history and progressive multiple sclerosis risk in womenBurcu Zeydan, Elizabeth J Atkinson, Delana M Weis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2020
Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesionsRoman M Kassa, Elia Sechi, Eoin P Flanagan, et al.
Archives of Neurology|March 16, 2011
Beneficial plasma exchange response in central nervous system inflammatory demyelinationSetty M Magaña, B Mark Keegan, Brian G Weinshenker, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2018
Population-based study of "no evident disease activity" in MSNatalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Journal of Neuroimmunology|March 26, 2025
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosisBurcu Zeydan, Nur Neyal, Nabeela Nathoo, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Archives of Neurology|September 16, 2009
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patientsAnu Jacob, Marcelo Matiello, Brian G Weinshenker, et al.
Biological Chemistry|July 17, 2008
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegenerationIsobel A Scarisbrick, Rachel Linbo, Alexander G Vandell, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Multiple Sclerosis and Related Disorders|June 10, 2026
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndromeAlbert Aboseif, Nur Neyal, B Mark Keegan, et al.
Neurology|June 26, 2019
Aquaporin-4 and MOG autoantibody discovery in idiopathic transverse myelitis epidemiologyElia Sechi, Eslam Shosha, Jonathan P Williams, et al.
Brain Communications|January 7, 2021
Reproductive history and progressive multiple sclerosis risk in womenBurcu Zeydan, Elizabeth J Atkinson, Delana M Weis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 16, 2020
Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesionsRoman M Kassa, Elia Sechi, Eoin P Flanagan, et al.
Archives of Neurology|March 16, 2011
Beneficial plasma exchange response in central nervous system inflammatory demyelinationSetty M Magaña, B Mark Keegan, Brian G Weinshenker, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2018
Population-based study of "no evident disease activity" in MSNatalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Journal of Neuroimmunology|March 26, 2025
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosisBurcu Zeydan, Nur Neyal, Nabeela Nathoo, et al.
Pageof 9